ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 100 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,743 | -87.2% | 17,302 | -78.1% | 0.00% | – |
| Q2 2023 | $99,377 | +507.7% | 78,871 | +249.6% | 0.00% | – |
| Q1 2023 | $16,354 | -29.5% | 22,561 | -48.6% | 0.00% | – |
| Q4 2022 | $23,186 | +157.6% | 43,871 | +295.2% | 0.00% | – |
| Q3 2022 | $9,000 | -89.5% | 11,100 | -86.0% | 0.00% | – |
| Q2 2022 | $86,000 | -67.5% | 79,287 | -62.5% | 0.00% | – |
| Q1 2022 | $265,000 | -84.5% | 211,658 | -80.3% | 0.00% | – |
| Q4 2021 | $1,714,000 | -73.1% | 1,072,095 | -45.2% | 0.00% | -100.0% |
| Q3 2021 | $6,377,000 | -81.9% | 1,956,041 | -64.9% | 0.00% | -84.6% |
| Q2 2021 | $35,232,000 | +2148.4% | 5,574,749 | +650.6% | 0.01% | +1200.0% |
| Q1 2021 | $1,567,000 | +6713.0% | 742,710 | +3224.7% | 0.00% | – |
| Q4 2018 | $23,000 | -43.9% | 22,339 | -5.3% | 0.00% | – |
| Q3 2018 | $41,000 | – | 23,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |